MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1182/blood-2010-02-268003

Медицинская библиотека · Blood · 2010

Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma.

Richter-Larrea Jose A, Robles Eloy F, Fresquet Vicente, Beltran Elena, Rullan Antonio J, Agirre Xabier, Calasanz Maria José, Panizo Carlos, Richter Jose A, Hernandez Jesus M, Roman-Gomez Jose, Prosper Felipe, Martinez-Climent Jose A

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

In Burkitt lymphoma/leukemia (BL), achievement of complete remission with first-line chemotherapy remains a challenging issue, as most patients who respond remain disease-free, whereas those refractory have few options of being rescued with salvage therapies. The mechanisms underlying BL chemoresistance and how it can be circumvented remain undetermined. We previously reported the frequent inactivation of the proapoptotic BIM gene in B-cell lymphomas. Here we show that BIM epigenetic silencing by concurrent promoter hypermethylation and deacetylation occurs frequently in primary BL samples and BL-derived cell lines. Remarkably, patients with BL with hypermethylated BIM presented lower complete remission rate (24% vs 79%; P = .002) and shorter overall survival (P = .007) than those with BIM-expressing lymphomas, indicating that BIM transcriptional repression may mediate tumor chemoresistance. Accordingly, by combining in vitro and in vivo studies of human BL-xenografts grown in immunodeficient RAG2(-/-)γc(-/-) mice and of murine B220(+)IgM(+) B-cell lymphomas generated in Eμ-MYC and Eμ-MYC-BIM(+/-) transgenes, we demonstrate that lymphoma chemoresistance is dictated by BIM gene dosage and is reversible on BIM reactivation by genetic manipulation or after treatment with histone-deacetylase inhibitors. We suggest that the combination of histone-deacetylase inhibitors and high-dose chemotherapy may overcome chemoresistance, achieve durable remission, and improve survival of patients with BL.

Для цитирования: Richter-Larrea Jose A, Robles Eloy F, Fresquet Vicente, Beltran Elena, Rullan Antonio J, Agirre Xabier, Calasanz Maria José, Panizo Carlos, Richter Jose A, Hernandez Jesus M, Roman-Gomez Jose, Prosper Felipe, Martinez-Climent Jose A. Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma.. Blood. 2010. DOI: 10.1182/blood-2010-02-268003.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.